Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease

Citation
M. Ringhoffer et al., Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease, BONE MAR TR, 28(6), 2001, pp. 615-618
Citations number
12
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Journal title
BONE MARROW TRANSPLANTATION
ISSN journal
02683369 → ACNP
Volume
28
Issue
6
Year of publication
2001
Pages
615 - 618
Database
ISI
SICI code
0268-3369(200109)28:6<615:FOIAPD>2.0.ZU;2-L
Abstract
A 51-year-old female patient in the first chronic phase of CML received an allogeneic PBSCT from a matched unrelated donor. The transplant was manipul ated by CD34(+) cell selection. On day +193 after transplantation the patie nt was readmitted to the hospital with recurrent fever of unknown origin an d cough. Clinical, radiographic and sonographic evaluation revealed no char acteristic findings besides a mild splenomegaly. Screening for EBV, CMV, RS V and HSV did not indicate an active infection. On day +203 the patient dev eloped generalized seizures, respiratory failure and died within 24 h in mu ltiorgan failure. The macroscopic postmortem was still not enlightening; th e histological examination however, demonstrated diffuse organ infiltration by monoclonal lymphoblastoid cells due to EBV-LPD.